Detalhe da pesquisa
1.
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101.
Proc Natl Acad Sci U S A
; 119(19): e2123483119, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507878
2.
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.
Clin Immunol
; 187: 37-45, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29031828
3.
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.
Immunity
; 28(4): 571-80, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18394936
4.
Cell-intrinsic abrogation of TGF-ß signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.
J Immunol
; 189(8): 3936-46, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984076
5.
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.
Int J Cancer
; 131(3): 662-72, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22275114
6.
Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.
J Immunol
; 183(8): 4848-52, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19801511
7.
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
Proc Natl Acad Sci U S A
; 105(9): 3509-14, 2008 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18303116
8.
Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Cancer Res
; 67(12): 5965-75, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575167
9.
Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.
Cancer Res
; 67(6): 2830-9, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17363606
10.
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.
Cancer Res
; 67(14): 6882-8, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17638899
11.
EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action.
Cancer Res
; 66(12): 6199-209, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16778194
12.
Targeting Aurora kinases for the treatment of prostate cancer.
Cancer Res
; 66(10): 4996-5002, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707419
13.
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
Prostate
; 67(1): 83-106, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17013881
14.
Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models.
Mol Cancer Res
; 4(12): 957-69, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17189386
15.
Pten dose dictates cancer progression in the prostate.
PLoS Biol
; 1(3): E59, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14691534
16.
Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Cancer Res
; 65(15): 6640-50, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061644
17.
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Cancer Res
; 65(5): 1761-9, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15753372
18.
beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Cancer Res
; 65(15): 6692-700, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061650
19.
A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model.
Cancer Res
; 65(14): 6337-45, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16024636
20.
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.
Mol Cancer Ther
; 5(7): 1733-43, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16891459